BP000181-CYT-264: Recombinant Human Fibroblast Growth Factor Acidic (FGF Acidic) Protein
Source: E. coli-derived.
The ED50, calculated by the dose-dependant proliferation of mouse BALB/c 3T3 cells is <0.5 ug/ml, corresponding to a specific activity of > 2.0 x 1,000,000 IU/mg.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000322-PRO-594: Recombinant Human FAS His Tag
Source: E.coli-derived.
Purity> 95%, by SDS-PAGE and RP-HPLC.BP000322-CYT-125: Recombinant Human FAS
Source: E.coli-derived.
The ED50 was determined by its ability to inhibit the cytotoxicity of Jurkat cells is between 10-15 ug/ml in the presence of 2 ug/ml of hFasL.
Purity> 95%, by SDS-PAGE and RP-HPLC.BP000016-PRO-566: Recombinant Human Fatty-acid Binding Protein 4, His Tag (FABP4)
Source: E. coli-derived.
Purity: > 95% by SDS-PAGE.BP000296-CHM-371: Recombinant Mouse Exodus-2 (CCL21)
Source: E. coli-derived.
Determined by its ability to chemoattract total murine T cell population using a concentration range of 10-100 ug/ml corresponding to a Specific Activity of 10,000-100,000 IU/mg.
Purity > 97%, by SDS-PAGE and RP-HPLC.BP000296-CHM-332: Recombinant Human Exodus-2 (CCL21)
Source: E. coli-derived.
Determined by its ability to chemoattract human total lymphocyte population using a concentration range of 10-100 ug/ml.
Purity > 97%, by SDS-PAGE and RP-HPLC.BP000180-CYT-325: Recombinant Human EPOα Fc-Chimera
Source: Chinese Hamster Ovary Cells(CHO)-derived.
The ED50 as determined by the dose-dependant stimulation of human megakaryoblastic leukemia cells is less than 2.0 ug/ml, corresponding to a Specific Activity of 0.5MIU/mg.
Purity > 98%, by SDS-PAGE and RP-HPLC.BP000180-CYT-083: Recombinant Human EPOα, HEK
Source: HEK-derived.
The specific activity was determined by the dose-dependent stimulation of the proliferation of human TF-1 cells (human erythroleukemic indicator cell line) and is typically 0.5-2.5 ug/ml.
Purity > 95%, by SDS-PAGE.BP000265-CHM-260: Recombinant Rat Eotaxin (CCL11)
Source: E. coli-derived.
Fully biologically active. Determined by its ability to chemoattract purified blood eosinophils using a concentration range of 0.1-1.0 ug/ml, corresponding to a Specific Activity of 10-100 IU/mg.
Purity > 97%, by SDS-PAGE and RP-HPLC.BP000265-CHM-344: Recombinant Human Eotaxin (CCL11), His Tag
Source: E. coli-derived.
Purity > 90%, by SDS-PAGE.